Physiologic Response to Gender-Affirming Hormones Among Transgender Youth
- PMID: 29056436
- PMCID: PMC7050572
- DOI: 10.1016/j.jadohealth.2017.08.005
Physiologic Response to Gender-Affirming Hormones Among Transgender Youth
Abstract
Purpose: The purpose of this study was to examine the physiologic impact of hormones on youth with gender dysphoria. These data represent follow-up data in youth ages 12-23 years over a two-year time period of hormone administration.
Methods: This prospective, longitudinal study initially enrolled 101 youth with gender dysphoria at baseline from those presenting consecutively for care between February 2011 and June 2013. Physiologic data at baseline and follow-up were abstracted from medical charts. Data were analyzed by descriptive statistics.
Results: Of the initial 101 participants, 59 youth had follow-up physiologic data collected between 21 and 31 months after initiation of hormones available for analysis. Metabolic parameters changes were not clinically significant, with the exception of sex steroid levels, intended to be the target of intervention.
Conclusions: Although the impact of hormones on some historically concerning physiologic parameters, including lipids, potassium, hemoglobin, and prolactin, were statistically significant, clinical significance was not observed. Hormone levels physiologically concordant with gender of identity were achieved with feminizing and masculinizing medication regimens. Extensive and frequent laboratory examination in transgender adolescents may be unnecessary. The use of hormones in transgender youth appears to be safe over a treatment course of approximately two years.
Keywords: Cross-sex hormones; Gender dysphoria; Gender transition; Transgender; Transgender youth.
Copyright © 2017 The Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.
Comment in
-
Collaboration Is Key to Developing Effective Hormonal Treatment Paradigms for Transgender Youth.J Adolesc Health. 2018 Apr;62(4):361-362. doi: 10.1016/j.jadohealth.2018.01.003. J Adolesc Health. 2018. PMID: 29571433 No abstract available.
Similar articles
-
Baseline Physiologic and Psychosocial Characteristics of Transgender Youth Seeking Care for Gender Dysphoria.J Adolesc Health. 2015 Oct;57(4):374-80. doi: 10.1016/j.jadohealth.2015.04.027. Epub 2015 Jul 21. J Adolesc Health. 2015. PMID: 26208863 Free PMC article.
-
Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.J Sex Med. 2020 Apr;17(4):812-825. doi: 10.1016/j.jsxm.2019.12.020. Epub 2020 Jan 31. J Sex Med. 2020. PMID: 32008926
-
Impact of Early Medical Treatment for Transgender Youth: Protocol for the Longitudinal, Observational Trans Youth Care Study.JMIR Res Protoc. 2019 Jul 9;8(7):e14434. doi: 10.2196/14434. JMIR Res Protoc. 2019. PMID: 31290407 Free PMC article.
-
MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.Eur J Endocrinol. 2021 Jun 28;185(2):R49-R63. doi: 10.1530/EJE-21-0059. Eur J Endocrinol. 2021. PMID: 34081614 Review.
-
Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.Curr Psychiatry Rep. 2018 Oct 11;20(12):110. doi: 10.1007/s11920-018-0973-0. Curr Psychiatry Rep. 2018. PMID: 30306351 Free PMC article. Review.
Cited by
-
The impact of gender-affirming hormone therapy on nutrition-relevant biochemical measures.Front Nutr. 2024 Apr 5;11:1339311. doi: 10.3389/fnut.2024.1339311. eCollection 2024. Front Nutr. 2024. PMID: 38646103 Free PMC article. Review.
-
Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals.J Endocrinol Invest. 2024 Mar 9. doi: 10.1007/s40618-024-02323-4. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38460092
-
Pelvic pain in transmasculine adolescents receiving testosterone therapy.Int J Transgend Health. 2022 Nov 24;25(1):10-18. doi: 10.1080/26895269.2022.2147118. eCollection 2024. Int J Transgend Health. 2022. PMID: 38323021 Free PMC article.
-
Une approche d'affirmation pour les soins aux jeunes transgenres et de diverses identités de genre.Paediatr Child Health. 2023 Oct 25;28(7):449-461. doi: 10.1093/pch/pxad046. eCollection 2023 Nov. Paediatr Child Health. 2023. PMID: 37885605 Review.
-
An affirming approach to caring for transgender and gender-diverse youth.Paediatr Child Health. 2023 Oct 25;28(7):437-448. doi: 10.1093/pch/pxad045. eCollection 2023 Nov. Paediatr Child Health. 2023. PMID: 37885600 Review.
References
-
- Spack NP, Edwards-Leeper L, Feldman HA, et al. Children and adolescents with gender identity disorder referred to a pediatric medical center. Pediatrics 2012;129. - PubMed
-
- Khatchadourian K, Amed S, Metzger DL. Clinical management of youth with gender dysphoria in Vancouver.J Pediatr 2014;164:906–11. - PubMed
-
- Smith YL, Van Goozen SH, Kuiper AJ, Cohen-Kettenis PT. Sex reassignment: Outcomes and predictors of treatment for adolescent and adult transsexuals. Psychol Med 2005;35:89–99. - PubMed
-
- Delemarre-van de Waal HA, Cohen-Kettenis PT. Clinical management of gender identity disorder in adolescents: A protocol on psychological and paediatric endocrinology aspects. Eur J Endocrinol 2006;155(Suppl. 1):S131–7.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical